Isavuconazole

Research use only, not for human use.

Isavuconazole(BAL-4815; RO-0094815) is the active component of the new azole antifungal agent BAL8557.

Isavuconazole(BAL-4815; RO-0094815) is the active component of the new azole antifungal agent BAL8557, exhibits MIC(50)s/MIC(90)s ranged from 0.002/0.004 mg/liter for C. albicans to 0.25/0.5 mg/liter for C. glabrata.(In Vitro):Isavuconazole (BAL-4815) shows good activity against all Candida spp., with active MIC50 of 0.004 mg/L. The MIC50s/MIC90s range from 0.002/0.004 mg/L for C. albicans to 0.25/0.5 mg/L for C. glabrata. Isavuconazole has potent in vitro activity against most common Aspergillus species, Purpureocillium lilacinum, and Scedosporium apiospermum. Isavuconazole shows potent activity against molds, yeasts, and dimorphic fungi. Rhizopus isolates have MIC values to isavuconazole as low as 0.12 μg/mL with others as high as 32 μg/mL. In the study of pharmacokinetics and pharmacodynamics of isavuconazole against the GFP transformant, F/11628, NIH 4215, and F/16216, the modal MICs of isavuconazole are 1, 8, 1, 4 mg/L, respectively.

——

——

BAL4815 | RO 0094815

Microbiology/Virology

Antifungal

Antifungle

Infection

——

241479-67-4

437.47

C22H17F2N5OS

>98% (HPLC)

DMSO: 10 mM

N#CC1=CC=C(C2=CSC([C@@H]([C@@](O)(C3=CC(F)=CC=C3F)CN4N=CN=C4)C)=N2)C=C1

4-(2-((2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)thiazol-4-yl)benzonitrile

(-20℃)

With Ice Pack

≥ 2 years